Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Low-dose nivolumab with neoadjuvant chemotherapy and oral metronomic therapy in borderline resectable oral cavity squamous cell carcinoma: a phase II trial.
Journal: The Lancet regional health. Southeast Asia
Published: October 04, 2025
Management and survival outcomes of desmoplastic small round cell tumor: a retrospective cohort study from a tertiary cancer center.
Journal: BMC cancer
Published: September 05, 2025
Low-dose nivolumab plus induction chemotherapy for locally advanced or unresectable head and neck cancer is associated with high response rates and conversion to definitive therapy.
Journal: Scientific reports
Published: April 06, 2025
Real-World Outcomes of Induction Chemotherapy With or Without Low-Dose Nivolumab for Stage III Non-Small Cell Lung Cancer Ineligible for Up-Front Local Therapy: A Propensity Score-Matched Analysis.
Journal: JCO global oncology
Published: March 24, 2025
Real world outcomes with Tepotinib in a series of Indian patients with MET exon 14 skipping positive non-small cell lung cancer.
Journal: Ecancermedicalscience
Published: January 27, 2025
Expression of Programmed Death Ligand 1 (PD-L1) in Classical Hodgkin Lymphoma- Study from a Tertiary Care Cancer Centre in South India.
Journal: Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion
Published: December 10, 2024
Intrathecal methotrexate induced subacute combined degeneration of spinal cord like presentation in a patient with acute lymphocytic leukaemia.
Journal: Acta neurologica Belgica
Published: April 13, 2023
Showing 1-7 of 7
Last Updated: 09/26/2026